The gene editing technologies market is driven by technological advancements enhancing precision, expanding applications in personalized medicine, and rising genetic disorder prevalence. Despite ...

For CPG brands already navigating evolving standards around transparency, sustainability and ingredient innovation, gene ...

The genetic code is the recipe for life, and provides the instructions for how to make proteins, generally using just 20 ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

A Japanese government expert panel agreed Thursday to legally ban and penalize research or medical practices that genetically ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

The MarketWatch News Department was not involved in the creation of this content.-- Kytopen continues expanding its partnership footprint in Europe through a new agreement with TQ ...

Higher yields, greater resilience to climatic changes or diseases—the demands on crop plants are constantly growing. To address these challenges, researchers of Karlsruhe Institute of Technology (KIT) ...

Xmoor expects to gain from direct collaboration with UCL’s translational researchers, enabling it to take part in technological innovation.

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research ...

Bristol and London, UK, 2 December 2025 - eXmoor Pharma, the UK’s only fully integrated cell and gene therapy CDMO with embedded consultancy expertise, and the Translational Research Office (TRO) at ...